Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Intermountain Health Care, Inc.
With
University of Utah
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult (age ≥ 18 years)
Confirmed OR suspected COVID-19,
* Confirmed: Positive assay for COVID-19 within the last 10 days
* Suspected: Pending assay for COVID-19 WITH high clinical suspicion
Scheduled for admission or already admitted to an inpatient bed
You may not be if
Allergy to hydroxychloroquine or azithromycin
History of bone marrow transplant
Known G6PD deficiency
Chronic hemodialysis or Glomerular Filtration Rate \< 20ml/min
Psoriasis
Porphyria
Concomitant use of digitalis, flecainide, amiodarone, procainamide, propafenone, cimetidine, dofetilide, phenobarbital, phenytoin, or sotalol
Known history of long QT syndrome
Current known QTc\>500 msec
Pregnant or nursing
Prisoner
Weight \< 35kg
Seizure disorder
Severe liver disease
Outpatient use of hydroxychloroquine for treatment of a disease other than COVID-19 OR has received more than 2 days of hydroxychloroquine or azithromycin for suspected or confirmed COVID-19
Patient has recovered from COVID-19 and/or is being discharged from the hospital on day of enrollment.
Treating physician refuses to allow patient participation in the study
Unable to obtain informed consent
Prior enrollment in this study
Clareo Health | Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19
